The Dayton Business Journal recently held a conversation focused on Mergers and Acquisitions in the Dayton region.

The two co-founders and leading executives of Germany’s BioNTech BNTX-Q will leave the COVID-19 vaccine maker by the end of 2026 to set up their own company, the biotech firm said on Tuesday. CEO Ugur ...